Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1707
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2635
    +0.0013 (+0.10%)
     
  • Bitcoin GBP

    54,758.50
    -1,666.85 (-2.95%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

Britain's FTSE slips as health stocks weaken

* Moody's cuts outlook on global pharma sector

* Inmarsat (Other OTC: IMASF - news) falls on outlook

* Admiral rises to record highs after results (Recasts, adds detail and updates prices)

By Kit Rees

LONDON, March 3 (Reuters) - Britain's top shares index slipped on Thursday, as weaker healthcare stocks weighed on the market, taking the shine off a rise in insurer Admiral.

The blue-chip FTSE 100 index was down 0.1 percent at 6,141.70 points in late session trading. The index is down around 2 percent since the start of 2016, and 14 percent below an April 2015 record high.

Healthcare stocks such as GlaxoSmithKline (Other OTC: GLAXF - news) and AstraZeneca (NYSE: AZN - news) fell after credit rating agency Moody's cut its outlook on the global pharmaceuticals industry to "stable" from "positive".

ADVERTISEMENT

Shares (Berlin: DI6.BE - news) in Whitbread - the company behind Premier Inns and Costa Coffee - fell 5.6 percent after a weak fourth quarter pergformance, while a cautious outlook hit the shares of satellite group Inmarsat.

Insurer Admiral Group was among the best performers, rising 8.4 percent to record highs after posting better-than-expected results. .

Aerospace engineering group Rolls Royce (LSE: RR.L - news) also rose 5 percent, lifted by a price target upgrade from investment bank Jefferies. (Editing by Jeremy Gaunt)